Stephen D. O’Flanagan

677 total citations
14 papers, 385 citations indexed

About

Stephen D. O’Flanagan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Stephen D. O’Flanagan has authored 14 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Stephen D. O’Flanagan's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Stephen D. O’Flanagan is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Stephen D. O’Flanagan collaborates with scholars based in United States. Stephen D. O’Flanagan's co-authors include Brandon J. Burbach, Samira M. Azarin, Qi Shao, John C. Bischof, Yoji Shimizu, David Masopust, Tiffany Lam, Vaiva Vezys, Sathi Wijeyesinghe and Andrew G. Soerens and has published in prestigious journals such as Nature Communications, Blood and Immunity.

In The Last Decade

Stephen D. O’Flanagan

13 papers receiving 378 citations

Peers

Countries citing papers authored by Stephen D. O’Flanagan

Since Specialization

Citations

This map shows the geographic impact of Stephen D. O’Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. O’Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. O’Flanagan more than expected).

Fields of papers citing papers by Stephen D. O’Flanagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. O’Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. O’Flanagan. The network helps show where Stephen D. O’Flanagan may publish in the future.

Co-authorship network of co-authors of Stephen D. O’Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. O’Flanagan. A scholar is included among the top collaborators of Stephen D. O’Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. O’Flanagan. Stephen D. O’Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiency 2025 ·Blood ·(unknown), (unknown), (unknown), Jeremy M. Chacón, Laura E. Bendzick, (unknown), Mihir Shetty, (unknown), (unknown), Juan E. Abrahante, Stephen D. O’Flanagan, (unknown), John R. Lozada, Stephen C. Jameson, Justin H. Hwang, Frank Cichocki, Martin Felices, Jeffrey S. Miller	0
2	Collaboration between interleukin-7 and -15 enables adaptation of tissue-resident and circulating memory CD8+ T cells to cytokine deficiency 2025 ·Immunity ·Nicholas N. Jarjour, (unknown), Nicholas J. Maurice, Kelsey M. Wanhainen, Changwei Peng, Stephen D. O’Flanagan, (unknown), Katharine E. Block, William J. Valente, (unknown), David Masopust, Stephen C. Jameson	2
3	Cutting Edge: First Lung Infection Permanently Enlarges Lymph Nodes and Enhances New T Cell Responses 2024 ·The Journal of Immunology ·J. Michael Stolley, Milcah C. Scott, Stephen D. O’Flanagan, Marco Künzli, (unknown), (unknown), Ryan A. Langlois, Vaiva Vezys, David Masopust	3
4	Deep profiling deconstructs features associated with memory CD8+ T cell tissue residence 2024 ·Immunity ·Milcah C. Scott, Zoë Steier, Mark Pierson, J. Michael Stolley, Stephen D. O’Flanagan, Andrew G. Soerens, Sathi Wijeyesinghe, Lalit K. Beura, (unknown), Brandon J. Burbach, Marco Künzli, Clare F. Quarnstrom, Olivia Smith, (unknown), Sara E. Hamilton, Vaiva Vezys, Alex K. Shalek, David Masopust	12
5	Chronic antigen in solid tumors drives a distinct program of T cell residence 2023 ·Science Immunology ·(unknown), Milcah C. Scott, (unknown), Olivia Smith, Stephen D. O’Flanagan, Sathi Wijeyesinghe, Sahar Lotfi‐Emran, Stephen L. Shiao, Vaiva Vezys, David Masopust	25
6	P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy 2022 ·Cancer Immunology Research ·Kelsey M. Wanhainen, Changwei Peng, (unknown), (unknown), Stephen D. O’Flanagan, (unknown), Ameeta Kelekar, Brandon J. Burbach, Henrique Borges da Silva, Stephen C. Jameson	19
7	Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells 2022 ·Science Immunology ·Marco Künzli, Stephen D. O’Flanagan, (unknown), (unknown), Thamotharampillai Dileepan, J. Michael Stolley, Andrew G. Soerens, Clare F. Quarnstrom, Sathi Wijeyesinghe, Yanqi Ye, Justine S. McPartlan, Jason S. Mitchell, Christian W. Mandl, Richard G. Vile, Marc K. Jenkins, Rafi Ahmed, Vaiva Vezys, Jasdave S. Chahal, David Masopust	45
8	1027 Chronic antigen in solid tumors drives a distinct program of T cell residence 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), Milcah C. Scott, (unknown), (unknown), Stephen D. O’Flanagan, Sathi Wijeyesinghe, Sahar Lotfi‐Emran, Stephen L. Shiao, Vaiva Vezys, David Masopust	4
9	Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells 2021 ·Nature Communications ·Brandon J. Burbach, Stephen D. O’Flanagan, Qi Shao, (unknown), (unknown), (unknown), (unknown), (unknown), Lalit K. Beura, Samira M. Azarin, S. Ramadhyani, (unknown), John C. Bischof, Yoji Shimizu	67
10	Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity 2021 ·The Journal of Immunology ·William E. Matchett, Vineet Joag, J. Michael Stolley, Frances K. Shepherd, Clare F. Quarnstrom, Clayton K. Mickelson, Sathi Wijeyesinghe, Andrew G. Soerens, (unknown), Joshua M. Thiede, (unknown), Stephen D. O’Flanagan, (unknown), Michelle N. Vu, Vineet D. Menachery, Tyler D. Bold, Vaiva Vezys, Marc K. Jenkins, Ryan A. Langlois, David Masopust	102
11	CD8+ T cell self-tolerance permits responsiveness but limits tissue damage 2021 ·eLife ·(unknown), Kristina S. Burrack, Todd P. Knutson, Henrique Borges da Silva, Katharine E. Block, Stephen D. O’Flanagan, (unknown), Arthur A. Hurwitz, Ross B. Fulton, Kristin R. Renkema, Stephen C. Jameson	9
12	Optimizing Integrated Electrode Design for Irreversible Electroporation of Implanted Polymer Scaffolds 2020 ·Annals of Biomedical Engineering ·(unknown), Qi Shao, (unknown), Tiffany Lam, Hak Rae Lee, Stephen D. O’Flanagan, (unknown), John C. Bischof, Samira M. Azarin	5
13	Tumor Ablation by Irreversible Electroporation (IRE) Augments CTLA-4 Checkpoint Inhibitor Immunotherapy 2019 ·Journal of the American College of Surgeons ·(unknown), Brandon J. Burbach, Stephen D. O’Flanagan, (unknown), (unknown), (unknown), Qi Shao, Samira M. Azarin, John C. Bischof, Yoji Shimizu	2
14	Engineering T cell response to cancer antigens by choice of focal therapeutic conditions 2019 ·International Journal of Hyperthermia ·Qi Shao, Stephen D. O’Flanagan, Tiffany Lam, (unknown), (unknown), Brandon J. Burbach, Samira M. Azarin, Yoji Shimizu, John C. Bischof	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact